Fate Therapeutics, Inc. (FATE)
NASDAQ·Healthcare·Biotechnology
$1.85
+1.09%
Mkt Cap $213.89M
Analyst Ratings
Buy
4
Hold
2
Sell
0
Price Target (24 analysts)
$5.63
Range $3.50 – $8.00
Implied Upside
+204.3%
Consensus $5.63 vs current $1.85
NASDAQ·Healthcare·Biotechnology
$1.85
+1.09%
Mkt Cap $213.89M
Buy
4
Hold
2
Sell
0
Price Target (24 analysts)
$5.63
Range $3.50 – $8.00
+204.3%
Consensus $5.63 vs current $1.85